<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Open Rheumatol J</journal-id><journal-id journal-id-type="iso-abbrev">Open Rheumatol J</journal-id><journal-id journal-id-type="publisher-id">TORJ</journal-id><journal-title-group><journal-title>The Open Rheumatology Journal</journal-title></journal-title-group><issn pub-type="epub">1874-3129</issn><publisher><publisher-name>Bentham Open</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27006727</article-id><article-id pub-id-type="pmc">4780524</article-id><article-id pub-id-type="publisher-id">TORJ-10-8</article-id><article-id pub-id-type="doi">10.2174/1874312901610010008</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>An Open Randomized Trial Comparing the Effects of Oral NSAIDs <italic>Versus</italic> Steroid Intra-Articular Infiltration in Congestive Osteoarthritis of the Knee</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dieu-Donn&#x000e9;</surname><given-names>Ou&#x000e9;draogo</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Th&#x000e9;odore</surname><given-names>Ou&#x000e9;draogo</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Jo&#x000eb;lle</surname><given-names>Zabsonr&#x000e9;/Tiendr&#x000e9;b&#x000e9;ogo</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Pierre</surname><given-names>Dionou</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Sma&#x000ef;la</surname><given-names>Ou&#x000e9;draogo</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Christian</surname><given-names>Compaor&#x000e9;</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Fulgence</surname><given-names>Kabor&#x000e9;</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Joseph</surname><given-names>Drabo Youssouf</given-names></name><xref ref-type="aff" rid="aff5">5</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Department of Rheumatology, University Hospital Yalgado Ouedraogo, Ouagadougou, Burkina Faso</aff><aff id="aff2"><label>2</label>Department of Anatomy; UFR SDS, University of Ouagadougou, Burkina Faso</aff><aff id="aff3"><label>3</label>Department of Epidemiology and Statistic, University Hospital Yalgado Ouedraogo, Ouagadougou, Burkina Faso</aff><aff id="aff4"><label>4</label>Department of Internal Medicine, International Polyclinic, Ouagadougou, Burkina Faso</aff><aff id="aff5"><label>5</label>Department of Internal Medicine, University Hospital Yalgado Ouedraogo, Ouagadougou, Burkina Faso</aff><author-notes><corresp id="cor1"><label>*</label>Address correspondence to this author at 09 BP 628 Ouagadougou. Burkina-Faso; Email: <email xlink:href="ouedd@yahoo.fr">ouedd@yahoo.fr</email></corresp></author-notes><pub-date pub-type="epub"><day>29</day><month>2</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>10</volume><fpage>8</fpage><lpage>12</lpage><history><date date-type="received"><day>29</day><month>8</month><year>2015</year></date><date date-type="rev-recd"><day>5</day><month>11</month><year>2015</year></date><date date-type="accepted"><day>5</day><month>11</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; Dieu-Donn&#x000e9; <italic>et al.</italic>; Licensee <italic>Bentham Open.</italic></copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Dieu-Donn&#x000e9;</copyright-holder><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/legalcode"><license-p> 
This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0)
(<uri xlink:type="simple" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/legalcode">https://creativecommons.org/licenses/by-nc/4.0/legalcode</uri>), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the
work is properly cited. </license-p></license></permissions><abstract><sec><title>Objective: </title><p>To compare the efficacy on pain and joint function of NSAIDs <italic>versus</italic> steroid intra-articular infiltration in congestive knee osteoarthritis.</p></sec><sec><title>Patients and Methods: </title><p>Open randomized study comparing a series of patients treated with NSAIDs for 21 days and another who received steroid intra-articular infiltration (SIAI) spaced at every 7 days. The visual analog scale was used for the weekly assessment of spontaneous pain and pain when walking. Lequesne functional pain scale was used to assess the functional impact of knee osteoarthritis.</p></sec><sec><title>Results: </title><p>Seventy patients were enrolled, including 35 in the NSAID arm and 35 in SIAI arm. Forty-nine (70%) had stage III of Kellgren and Lawrance scale. On admission, the average pain intensity was 50.46 &#x000b1; 30.93 in the NSAID arm and 60.92 &#x000b1; 30 in SIAI arm (p = 0.0189). At the end of follow-up, pain intensity was 6.72 &#x000b1; 13 in NSAIDs patients and 17.80 &#x000b1; 21 in SIAI one (p = 0.001). The average intensity of pain on walking was 64.41 &#x000b1; 22.61. It was 53.33 &#x000b1; 22.31 in NSAID&#x02019;s against 74.85 &#x000b1; 17.55 in SIAI patients (P &#x0003c;0.0001). At the end of the treatment, they were respectively 19.11 &#x000b1; 11.37, and 35 &#x000b1; 30.69 (P = 0.0085).</p></sec><sec><title>Conclusion: </title><p>Corticosteroid injections have a short efficacy compared to NSAIDs. Prescribing NSAIDs should consider the cons-indications, comorbidities and their deleterious digestive, renal, and cardiovascular effect.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>Cardiovascular effect</kwd><kwd>Knee osteoarthritis</kwd><kwd>NSAIDs</kwd><kwd>Steroid intra-articular injection</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>The non-steroidal anti-inflammatory drugs (NSAIDs) are known for their efficiency in the congestive osteoarthritis of the knee. Complications including cardiovascular were better documented in recent years and the indications most detailed [<xref rid="R1" ref-type="bibr">1</xref>].</p><p>Steroid intra-articular infiltration (SIAI) is an effective alternative [<xref rid="R2" ref-type="bibr">2</xref>]; however, their effect seems short, not more than two to three weeks. In practice, the choice of treatment, NSAIDs or SIAI is not codified and predictors of efficacy of SIAI little known [<xref rid="R3" ref-type="bibr">3</xref>]. Few studies have compared the efficacy of NSAIDs and SIAI in short and medium terms in knee osteoarthritis.</p><p>The objective of this study was to compare the efficacy on pain and joint function of drug treatment with NSAIDs <italic>versus</italic> SIAI in knee osteoarthritis in congestive thrust.</p></sec><sec sec-type="materials|methods"><title>Patients and methods</title><p>This was a prospective open randomized trial conducted from 15 July 2013 to 15 February 2014 in Rheumatology and Orthopedic Surgery department, at the University Hospital Yalgado Ouedraogo. Consenting patients coming in consultation for knee osteoarthritis in congestive thrust were included. Patients were openly randomized alternately in both parts and were monitored for 6 weeks either in consultation or by phone call. The patients who could not be monitored, changed treatment or associated other treatment were excluded from the study.</p><p>Diclofenac and aceclofenac were used respectively at a dose of 150 mg and 200 mg twice daily for 21 days. The cortivazol 3,75 mg or betamethasone 2 mg was used for intra-articular infiltration in a series of 3 injections spaced one week each. The algofunctional Lequesne index was assessed at the beginning and at the end of follow-up of each patient. The visual analog scale (0 to 100) was used to evaluate the intensity of pain whether spontaneous or when walking. If there is bilateral knee osteoarthritis, the most symptomatic knee was the target of the study.</p><p>The data were entered into computer and analyzed with the software Epi-Info version 3.5.1. Chi-square test and Fisher exact test were used to compare qualitative variables. The ANOVA test was used for comparison of means. The Statistical significance was &#x003b1; &#x0003c;0.05. Oral and informed consent was required.</p></sec><sec sec-type="results"><title>RESULTS</title><sec><title>Characteristics of the Target Population</title><p>Eighty-three patients were included during the study period. During follow-up, 13 patients were excluded, five due to self medication and additional eight due to the ineffectiveness of treatment. Seventy patients were selected including 35 treated with NSAIDs and 35 who received SIAI. The average age of patients was 53.04 years with extremes of 32 and 78 years. These were 60 women (85.7%) and ten men (14.3%) or a sex ratio of 0.16. Forty-nine patients (70%) had grade III of Kellgren and Lawrence scale. The average algofunctional Lequesne index was 8.48. Table <bold><xref ref-type="table" rid="T1">1</xref></bold> shows the other patient characteristics.</p></sec><sec><title>Assessment of Pain</title><p>The intensity of spontaneous pain was 50.46 &#x000b1; 30.93 in patients receiving NSAIDs and 63.92 &#x000b1; 30.07 for those who received SIAI (p = 0.0189). Fig. (<bold><xref ref-type="fig" rid="F1">1</xref></bold>) shows the evolution of the number of patients with spontaneous pain depending on the treatment.</p><p>At the end of follow-up, pain intensity was 6.72 &#x000b1; 13.75 in the population who received NSAIDs and 17.80 &#x000b1; 21.78 in the one having obtained the SIAI (p = 0.00101). Fig. (<bold><xref ref-type="fig" rid="F2">2</xref></bold>) shows the evolution of the intensity of spontaneous pain on processing.The average intensity of pain on walking was 64.41 &#x000b1; 22.61. It was 53.33 &#x000b1; 22.31 in NSAID against 74.85 &#x000b1; 17.55 in SIAI (P &#x0003c;0.0001). At the end of the treatment, they were respectively 19.11 &#x000b1; 11.37, and 35 &#x000b1; 30.69 (P = 0.0085). Fig. (<bold><xref ref-type="fig" rid="F3">3</xref></bold>) shows the change in the intensity of pain on walking after treatment.</p><p>Table <bold><xref ref-type="table" rid="T2">2</xref></bold> compares the effectiveness of NSAIDs <italic>vs.</italic> SIAI for different pain and the Lequesne index.</p></sec><sec><title>Comments</title><p>Few studies have compared the effectiveness of oral NSAIDs and SIAI in congestive knee osteoarthritis. Our study reports an efficiency of NSAIDs on steroid infiltration after a follow-up of 42 days.</p><p>While the general patient characteristics are similar to other African series [<xref rid="R4" ref-type="bibr">4</xref>-<xref rid="R6" ref-type="bibr">6</xref>], there is difference between the two parts at inclusion which may constitute a bias; indeed, pain and functional impairment was higher in the part of patients with SIAI. Recently, a study of 32 patients with shoulder impingement syndrome showed the effectiveness of NSAIDs on the steroid injection; this efficiency is expressed in terms of gain in shoulder mobility assessed after one month of follow-up [<xref rid="R7" ref-type="bibr">7</xref>]. However, it seems to have no significant difference between the oral NSAIDs and steroid infiltration in treating carpal tunnel syndrome [<xref rid="R8" ref-type="bibr">8</xref>]. Instead, in the tendinitis of the shoulder and elbow, the efficacy of corticosteroid injections seems short [<xref rid="R9" ref-type="bibr">9</xref>]. This short-term efficacy also has been reported in knee osteoarthritis [<xref rid="R10" ref-type="bibr">10</xref>]. Indeed, from the seventh day of treatment, the number of patients with spontaneous pain in the NSAIDs part was significantly less than in patients who have received SIAI. Predictors of efficacy in the short and medium term of SIAI are not well known; however, the severity of the disease, the absence of synovitis in ultrasound, the presence of intra-articular effusion seem to lead to a more effective response [<xref rid="R11" ref-type="bibr">11</xref>, <xref rid="R12" ref-type="bibr">12</xref>]. Our series was characterized by the severity of knee osteoarthritis (Lequesne index to 8.48) and an intra articular effusion in all patients; the superiority of infiltration lasted only one week despite that two other infiltrations have been made. These results suggest that a combination of both treatments may be performed. This could make a single steroid infiltration on the first day followed by treatment of NSAID per os. This scheme would have the advantage of reducing the risk of infection that could be linked to the last two corticosteroid injections. Other studies, including the protocol to the two described here could better appreciate the superiority of a protocol on the other and tolerance in the patient.</p></sec></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>SIAI seems to have a brief efficiency. The oral NSAIDs have the advantage of maintaining a relief in the period compared to steroid intra-articular infiltration. Their prescription should consider the contraindications and their deleterious effects including gastrointestinal, renal, and cardiovascular effects. The difference in the average ages of the 2 groups could be a limitation of the study</p></sec></body><back><ack><title>ACKNOWLEDGEMENTS</title><p>Declared none.</p></ack><sec><title>CONFLICT OF INTEREST</title><p>The authors confirm that this article content has no conflict of interest.</p></sec><ref-list><title>REFERENCES</title><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruy&#x000e8;re</surname><given-names>O.</given-names></name><name><surname>Cooper</surname><given-names>C.</given-names></name><name><surname>Pelletier</surname><given-names>J.P.</given-names></name><name><surname>Branco</surname><given-names>J.</given-names></name><name><surname>Luisa Brandi</surname><given-names>M.</given-names></name><name><surname>Guillemin</surname><given-names>F.</given-names></name><name><surname>Hochberg</surname><given-names>M.C.</given-names></name><name><surname>Kanis</surname><given-names>J.A.</given-names></name><name><surname>Kvien</surname><given-names>T.K.</given-names></name><name><surname>Martel-Pelletier</surname><given-names>J.</given-names></name><name><surname>Rizzoli</surname><given-names>R.</given-names></name><name><surname>Silverman</surname><given-names>S.</given-names></name><name><surname>Reginster</surname><given-names>J.Y.</given-names></name></person-group><article-title>An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).</article-title><source>Semin. Arthritis Rheum.</source><year>2014</year><volume>44</volume><issue>3</issue><fpage>253</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1016/j.semarthrit.2014.05.014</pub-id><pub-id pub-id-type="pmid">24953861</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konai</surname><given-names>M.S.</given-names></name><name><surname>Vilar Furtado</surname><given-names>R.N.</given-names></name><name><surname>Dos Santos</surname><given-names>M.F.</given-names></name><name><surname>Natour</surname><given-names>J.</given-names></name></person-group><article-title>Monoarticular corticosteroid injection <italic>versus</italic> systemic administration in the treatment of rheumatoid arthritis patients: a randomized double-blind controlled study.</article-title><source>Clin. Exp. Rheumatol.</source><year>2009</year><volume>27</volume><issue>2</issue><fpage>214</fpage><lpage>221</lpage><pub-id pub-id-type="pmid">19473560</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirsch</surname><given-names>G.</given-names></name><name><surname>Kitas</surname><given-names>G.</given-names></name><name><surname>Klocke</surname><given-names>R.</given-names></name></person-group><article-title>Intra-articular corticosteroid injection in osteoarthritis of the knee and hip: factors predicting pain relief--a systematic review.</article-title><source>Semin. Arthritis Rheum.</source><year>2013</year><volume>42</volume><issue>5</issue><fpage>451</fpage><lpage>473</lpage><pub-id pub-id-type="doi">10.1016/j.semarthrit.2012.08.005</pub-id><pub-id pub-id-type="pmid">23374502</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mijiyawa</surname><given-names>M.</given-names></name></person-group><article-title>Rheumatic diseases in black Africa.</article-title><source>Rev. Rhum. Ed Fr.</source><year>1993</year><volume>60</volume><issue>6</issue><fpage>451</fpage><lpage>457</lpage><pub-id pub-id-type="pmid">8124280</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eti</surname><given-names>E.</given-names></name><name><surname>Kouakou</surname><given-names>H.B.</given-names></name><name><surname>Daboiko</surname><given-names>J.C.</given-names></name><name><surname>Ouali</surname><given-names>B.</given-names></name><name><surname>Ouattara</surname><given-names>B.</given-names></name><name><surname>Gabla</surname><given-names>K.A.</given-names></name><name><surname>Kouakou</surname><given-names>M.N.</given-names></name></person-group><article-title>Epidemiology and features of knee osteoarthritis in the Ivory Coast.</article-title><source>Rev. Rhum. Engl. Ed.</source><year>1998</year><volume>65</volume><issue>12</issue><fpage>766</fpage><lpage>770</lpage><pub-id pub-id-type="pmid">9923045</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ou&#x000e9;draogo</surname><given-names>D.D.</given-names></name><name><surname>S&#x000e9;ogo</surname><given-names>H.</given-names></name><name><surname>Ciss&#x000e9;</surname><given-names>R.</given-names></name><name><surname>Ti&#x000e9;no</surname><given-names>H.</given-names></name><name><surname>Ou&#x000e9;draogo</surname><given-names>T.</given-names></name><name><surname>Nacoulma</surname><given-names>I.S.</given-names></name><name><surname>Drabo</surname><given-names>Y.J.</given-names></name></person-group><article-title>Risk factors associated with osteoarthritis of the knee in a rheumatology outpatient clinic in Ouagadougou, Burkina Faso.</article-title><source>Med. Trop. (Mars.)</source><year>2008</year><volume>68</volume><issue>6</issue><fpage>597</fpage><lpage>599</lpage><pub-id pub-id-type="pmid">19639826</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Min</surname><given-names>K.S.</given-names></name><name><surname>St Pierre</surname><given-names>P.</given-names></name><name><surname>Ryan</surname><given-names>P.M.</given-names></name><name><surname>Marchant</surname><given-names>B.G.</given-names></name><name><surname>Wilson</surname><given-names>C.J.</given-names></name><name><surname>Arrington</surname><given-names>E.D.</given-names></name></person-group><article-title>A double-blind randomized controlled trial comparing the effects of subacromial injection with corticosteroid <italic>versus</italic> NSAID in patients with shoulder impingement syndrome.</article-title><source>J. Shoulder Elbow Surg.</source><year>2013</year><volume>22</volume><issue>5</issue><fpage>595</fpage><lpage>601</lpage><pub-id pub-id-type="doi">10.1016/j.jse.2012.08.026</pub-id><pub-id pub-id-type="pmid">23177167</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurcay</surname><given-names>E.</given-names></name><name><surname>Unlu</surname><given-names>E.</given-names></name><name><surname>Gurcay</surname><given-names>A.G.</given-names></name><name><surname>Tuncay</surname><given-names>R.</given-names></name><name><surname>Cakci</surname><given-names>A.</given-names></name></person-group><article-title>Evaluation of the effect of local corticosteroid injection and anti-inflammatory medication in carpal tunnel syndrome.</article-title><source>Scott. Med. J.</source><year>2009</year><volume>54</volume><issue>1</issue><fpage>4</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1258/rsmsmj.54.1.4</pub-id><pub-id pub-id-type="pmid">19291926</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaujoux-Viala</surname><given-names>C.</given-names></name><name><surname>Dougados</surname><given-names>M.</given-names></name><name><surname>Gossec</surname><given-names>L.</given-names></name></person-group><article-title>Efficacy and safety of steroid injections for shoulder and elbow tendonitis: a meta-analysis of randomised controlled trials.</article-title><source>Ann. Rheum. Dis.</source><year>2009</year><volume>68</volume><issue>12</issue><fpage>1843</fpage><lpage>1849</lpage><pub-id pub-id-type="doi">10.1136/ard.2008.099572</pub-id><pub-id pub-id-type="pmid">19054817</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellamy</surname><given-names>N.</given-names></name><name><surname>Campbell</surname><given-names>J.</given-names></name><name><surname>Robinson</surname><given-names>V.</given-names></name><name><surname>Gee</surname><given-names>T.</given-names></name><name><surname>Bourne</surname><given-names>R.</given-names></name><name><surname>Wells</surname><given-names>G.</given-names></name></person-group><article-title>Intraarticular corticosteroid for treatment of osteoarthritis of the knee.</article-title><source>Cochrane Database Syst. Rev.</source><year>2005</year><volume>18</volume><issue>2</issue><fpage>CD005328</fpage><pub-id pub-id-type="pmid">15846755</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maricar</surname><given-names>N.</given-names></name><name><surname>Callaghan</surname><given-names>M.J.</given-names></name><name><surname>Felson</surname><given-names>D.T.</given-names></name><name><surname>O&#x02019;Neill</surname><given-names>T.W.</given-names></name></person-group><article-title>Predictors of response to intra-articular steroid injections in knee osteoarthritis--a systematic review.</article-title><source>Rheumatology (Oxford)</source><year>2013</year><volume>52</volume><issue>6</issue><fpage>1022</fpage><lpage>1032</lpage><pub-id pub-id-type="doi">10.1093/rheumatology/kes368</pub-id><pub-id pub-id-type="pmid">23264554</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>C.</given-names></name><name><surname>Sun</surname><given-names>B.</given-names></name><name><surname>Hose</surname><given-names>M.K.</given-names></name><name><surname>Quan</surname><given-names>A.</given-names></name><name><surname>Hughes</surname><given-names>T.H.</given-names></name><name><surname>Boyle</surname><given-names>D.</given-names></name><name><surname>Kalunian</surname><given-names>K.C.</given-names></name></person-group><article-title>Inflammatory characteristics on ultrasound predict poorer longterm response to intraarticular corticosteroid injections in knee osteoarthritis.</article-title><source>J. Rheumatol.</source><year>2010</year><volume>37</volume><issue>3</issue><fpage>650</fpage><lpage>655</lpage><pub-id pub-id-type="doi">10.3899/jrheum.090575</pub-id><pub-id pub-id-type="pmid">20080918</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Fig. (1)</label><caption><p>Evolution of the number of patients with spontaneous pain depending on the type of treatment.</p></caption><graphic xlink:href="TORJ-10-8_F1"/></fig><fig id="F2" position="float"><label>Fig. (2)</label><caption><p>Evolution of the intensity of spontaneous pain depending on the type of treatment.</p></caption><graphic xlink:href="TORJ-10-8_F2"/></fig><fig id="F3" position="float"><label>Fig. (3)</label><caption><p>Evolution of pain intensity due to walking according to the type of treatment.</p></caption><graphic xlink:href="TORJ-10-8_F3"/></fig><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Patient characteristics.</p></caption><table frame="border" rules="all" width="100%"><thead><tr><th align="center" rowspan="1" colspan="1">
</th><th align="center" rowspan="1" colspan="1">&#x02003;</th><th align="center" rowspan="1" colspan="1">NSAIDs </th><th align="center" rowspan="1" colspan="1">SIAI </th><th align="center" rowspan="1" colspan="1">Probability</th></tr></thead><tbody><tr><td valign="middle" align="center" rowspan="1" colspan="1">&#x02003;
Average age (years)</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02003;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02003;
59.68</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02003;
46.40</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02003;
0.005</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">Body mass index (kg/m2)</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02003;</td><td valign="middle" align="center" rowspan="1" colspan="1">28.60&#x000b1;5</td><td valign="middle" align="center" rowspan="1" colspan="1">30.21&#x000b1;4.93</td><td valign="middle" align="center" rowspan="1" colspan="1">0.07</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">Topography of knee osteoarthritis</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02003;</td><td valign="middle" align="center" rowspan="1" colspan="1"/><td valign="middle" align="center" rowspan="1" colspan="1">&#x02003;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02003;</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1"/><td valign="middle" align="center" rowspan="1" colspan="1">PF<xref ref-type="table-fn" rid="T1F1">*</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">2</td><td valign="middle" align="center" rowspan="1" colspan="1">2</td><td valign="middle" align="center" rowspan="1" colspan="1">0.12</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1"/><td valign="middle" align="center" rowspan="1" colspan="1">FT<xref ref-type="table-fn" rid="T1F2">**</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">14</td><td valign="middle" align="center" rowspan="1" colspan="1">5</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02003;</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1"/><td valign="middle" align="center" rowspan="1" colspan="1">Overall</td><td valign="middle" align="center" rowspan="1" colspan="1">19</td><td valign="middle" align="center" rowspan="1" colspan="1">28</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02003;</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">Kellgren and Lawrence classification</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02003;</td><td valign="middle" align="center" rowspan="1" colspan="1"/><td valign="middle" align="center" rowspan="1" colspan="1">&#x02003;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02003;</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1"/><td valign="middle" align="center" rowspan="1" colspan="1">Stage 1</td><td valign="middle" align="center" rowspan="1" colspan="1">1</td><td valign="middle" align="center" rowspan="1" colspan="1">1</td><td valign="middle" align="center" rowspan="1" colspan="1">0.064</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1"/><td valign="middle" align="center" rowspan="1" colspan="1">Stage 2</td><td valign="middle" align="center" rowspan="1" colspan="1">7</td><td valign="middle" align="center" rowspan="1" colspan="1">0</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02003;</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1"/><td valign="middle" align="center" rowspan="1" colspan="1">Stage 3</td><td valign="middle" align="center" rowspan="1" colspan="1">25</td><td valign="middle" align="center" rowspan="1" colspan="1">24</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02003;</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1"/><td valign="middle" align="center" rowspan="1" colspan="1">Stage 4</td><td valign="middle" align="center" rowspan="1" colspan="1">2</td><td valign="middle" align="center" rowspan="1" colspan="1">10</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02003;</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">Affected knee</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02003;</td><td valign="middle" align="center" rowspan="1" colspan="1"/><td valign="middle" align="center" rowspan="1" colspan="1">&#x02003;</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02003;</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1"/><td valign="middle" align="center" rowspan="1" colspan="1">Right</td><td valign="middle" align="center" rowspan="1" colspan="1">20</td><td valign="middle" align="center" rowspan="1" colspan="1">18</td><td valign="middle" align="center" rowspan="1" colspan="1">0.07</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1"/><td valign="middle" align="center" rowspan="1" colspan="1">Left</td><td valign="middle" align="center" rowspan="1" colspan="1">15</td><td valign="middle" align="center" rowspan="1" colspan="1">17</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02003;</td></tr></tbody></table><table-wrap-foot><fn id="T1F1"><p> * Patello-femoral</p></fn><fn id="T1F2"><p> ** Femoral-tibial</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Comparative efficacy of NSAIDs <italic>versus</italic> SIAI on pain and Lequesne index at D0 and D42.</p></caption><table frame="border" rules="all" width="100%"><thead><tr><th align="center" rowspan="1" colspan="1">&#x02003;</th><th colspan="2" align="center" rowspan="1">&#x02003; NSAIDs (n = 35)</th><th colspan="2" align="center" rowspan="1">SIAI (n = 35)</th><th align="center" rowspan="1" colspan="1">Probability</th></tr><tr><th valign="middle" align="center" rowspan="1" colspan="1">&#x02003;</th><th valign="middle" align="center" rowspan="1" colspan="1">D0</th><th valign="middle" align="center" rowspan="1" colspan="1">D42</th><th valign="middle" align="center" rowspan="1" colspan="1">D0</th><th valign="middle" align="center" rowspan="1" colspan="1">D42</th><th valign="middle" align="center" rowspan="1" colspan="1">&#x02003;</th></tr></thead><tbody><tr><td valign="middle" align="center" rowspan="1" colspan="1">VAS average</td><td valign="middle" align="center" rowspan="1" colspan="1">50.5</td><td valign="middle" align="center" rowspan="1" colspan="1">6.7</td><td valign="middle" align="center" rowspan="1" colspan="1">63.9</td><td valign="middle" align="center" rowspan="1" colspan="1">17.8</td><td valign="middle" align="center" rowspan="1" colspan="1">0.0001</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">Spontaneous pain (%)</td><td valign="middle" align="center" rowspan="1" colspan="1">83</td><td valign="middle" align="center" rowspan="1" colspan="1">11.4</td><td valign="middle" align="center" rowspan="1" colspan="1">100</td><td valign="middle" align="center" rowspan="1" colspan="1">37.1</td><td valign="middle" align="center" rowspan="1" colspan="1">0.0012</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">Walking pain (%)</td><td valign="middle" align="center" rowspan="1" colspan="1">97</td><td valign="middle" align="center" rowspan="1" colspan="1">57</td><td valign="middle" align="center" rowspan="1" colspan="1">100</td><td valign="middle" align="center" rowspan="1" colspan="1">74.2</td><td valign="middle" align="center" rowspan="1" colspan="1">0.002</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">Pain when standing (%)</td><td valign="middle" align="center" rowspan="1" colspan="1">68.6</td><td valign="middle" align="center" rowspan="1" colspan="1">34.2</td><td valign="middle" align="center" rowspan="1" colspan="1">77.1</td><td valign="middle" align="center" rowspan="1" colspan="1">54.2</td><td valign="middle" align="center" rowspan="1" colspan="1">0.008</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">Prolonged standing pain (%)</td><td valign="middle" align="center" rowspan="1" colspan="1">71.4</td><td valign="middle" align="center" rowspan="1" colspan="1">25.7</td><td valign="middle" align="center" rowspan="1" colspan="1">91.4</td><td valign="middle" align="center" rowspan="1" colspan="1">51.4</td><td valign="middle" align="center" rowspan="1" colspan="1">0.0003</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">Means Lequesne index</td><td valign="middle" align="center" rowspan="1" colspan="1">6.6</td><td valign="middle" align="center" rowspan="1" colspan="1">2.4</td><td valign="middle" align="center" rowspan="1" colspan="1">10.3</td><td valign="middle" align="center" rowspan="1" colspan="1">5.1</td><td valign="middle" align="center" rowspan="1" colspan="1">0.0001</td></tr></tbody></table><table-wrap-foot><fn id="T2F1"><p> % = percentage of patients with pain</p><p>VAS: Visual Analog Scale </p></fn></table-wrap-foot></table-wrap></floats-group></article>